Takeda and Cour to develop new therapies to treat celiac disease

Japan-based Takeda Pharmaceutical and US firm Cour Pharmaceutical Development Company have collaborated to research and develop new immune modulating therapies for the potential treatment of celiac disease.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news